Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

We recently published 10 Best Biotech Stocks to Buy Under $10. Recursion Pharmaceuticals, Inc. is placed eighth among them. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a clinical-stage ...

84% of developers surveyed by Stack Overflow either use or plan to use AI tools, while 64% cited ‘almost right’ AI output and debugging AI code as their top frustrations. While the number of ...

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline. Shrinking the Salt Lake City-based company’s ...

It would be easy to say that artificial intelligence killed off Stack Overflow, but it would be truer to say that AI delivered the final blow. What really happened is a parable of human community and ...

The question-and-answer site Stack Overflow was founded 17 years ago to allow programmers -- human programmers -- to post questions about programming problems and get answers from a community of ...

In this year's big Stack Overflow developer survey things are much the same for Microsoft-centric data points: VS Code and Visual Studio still rule the IDE roost, while .NET maintains its No. 1 ...

Artificial intelligence (AI)-based drug developer Recursion said it has completed the fastest supercomputer to be wholly owned and operated by any pharmaceutical company worldwide, using technology ...